These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
676 related items for PubMed ID: 25487027
1. Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome. Jee D, Park M, Lee HJ, Kim MS, Kim EC. J Cataract Refract Surg; 2015 Apr; 41(4):756-63. PubMed ID: 25487027 [Abstract] [Full Text] [Related]
2. Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops. Jee D, Park SH, Kim MS, Kim EC. Invest Ophthalmol Vis Sci; 2014 Jul 03; 55(8):5081-9. PubMed ID: 24994869 [Abstract] [Full Text] [Related]
3. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops. Hwang HS, Sung YM, Lee WS, Kim EC. Cornea; 2014 Sep 03; 33(9):935-41. PubMed ID: 25055152 [Abstract] [Full Text] [Related]
4. Effect of a hyaluronic acid and carboxymethylcellulose ophthalmic solution on ocular comfort and tear-film instability after cataract surgery. Mencucci R, Boccalini C, Caputo R, Favuzza E. J Cataract Refract Surg; 2015 Aug 03; 41(8):1699-704. PubMed ID: 26432128 [Abstract] [Full Text] [Related]
5. Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial. Park DH, Chung JK, Seo DR, Lee SJ. Am J Ophthalmol; 2016 Mar 03; 163():122-131.e2. PubMed ID: 26685791 [Abstract] [Full Text] [Related]
6. A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye. Kinoshita S, Oshiden K, Awamura S, Suzuki H, Nakamichi N, Yokoi N, Rebamipide Ophthalmic Suspension Phase 3 Study Group. Ophthalmology; 2013 Jun 03; 120(6):1158-65. PubMed ID: 23490326 [Abstract] [Full Text] [Related]
7. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease. Lee HS, Ji YS, Yoon KC. Cornea; 2014 Sep 03; 33(9):946-51. PubMed ID: 24915018 [Abstract] [Full Text] [Related]
10. Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery. Maca SM, Amon M, Findl O, Kahraman G, Barisani-Asenbauer T. Am J Ophthalmol; 2010 May 03; 149(5):777-84. PubMed ID: 20152959 [Abstract] [Full Text] [Related]
11. Comparison of a preservative-free nonsteroidal anti-inflammatory drug and preservative-free corticosteroid after uneventful cataract surgery: multicenter, randomized, evaluator-blinded clinical trial. Kim S, Ko BY, Koh JW, Kim EC, Kim HK, Shin YJ, Song JS, Lee DH, Lee JE, Lee HK, Chung SH, Kim HS. J Cataract Refract Surg; 2022 Jun 01; 48(6):710-716. PubMed ID: 34629379 [Abstract] [Full Text] [Related]
12. Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model. Zhu L, Zhang C, Chuck RS. Mol Vis; 2012 Jun 01; 18():1803-12. PubMed ID: 22815633 [Abstract] [Full Text] [Related]
16. The effect of sodium hyaluronate on dry eye and corneal epithelial thickness following cataract surgery. Yusufoğlu E, Keser S. Int Ophthalmol; 2024 May 02; 44(1):211. PubMed ID: 38696090 [Abstract] [Full Text] [Related]